The European IN-ARMOR project coordinates its upcoming milestones at the 12th meeting of its Management Board

The international consortium of the IN-ARMOR project, funded by the European Commission’s Horizon Europe programme, held its 12th Management Board Meeting on 12 March. The meeting served to consolidate the scientific progress achieved in recent months and to establish the strategic foundations for the project’s next evaluation phase.

Status update and progress of the Work Packages

During the session, each Work Package presented a detailed update on their activities. This technical review enabled the consortium to verify the achievement of intermediate objectives in critical areas such as the development of new immunotherapies to tackle antimicrobial resistance. The exchange of results among partners highlighted the strong synergy within the consortium, showcasing the maturity of the research and the proper execution of the trials and validations planned in the timeline.

Preparations for the 2nd Reporting Period

A key point on the agenda was the start of planning for the second reporting period (RP2) to the European Commission. This administrative and technical milestone is essential to ensure transparency and excellence in project management, guaranteeing that all achievements are documented in line with Horizon Europe standards.

Acknowledgement to the consortium

At Biokeralty, as an active member of this innovation ecosystem, we would like to express our sincere gratitude to all partners for their commitment, technical excellence and collaborative spirit. Thanks to this collective effort, we continue to advance in the development of innovative tools to protect people’s health against infectious threats.

Want to know more? Find us and follow us on LinkedIn, X and Bluesky to stay up to date with all project milestones.